12/04/2017Antibody Solutions + Single Cell Technology, Inc. Partnership Expands Access to Single B-Cell Antibody Discovery
New offering aims to advance researchers’ ability to develop broader repertoire of novel antibody candidates Sunnyvale, Calif. (Dec. 4, 2017) – Antibody Solutions, a leader in discovery of therapeutic, biomarker and critical reagent antibodies, and Single Cell Technology, Inc. (SCT), a pioneer in single cell analysis technology, have launched a partnership that offers pharmaceutical researchers one-stop access to advanced single B-cell antibody discovery capabilities. The new Single B-Cell Antibody Discovery service combines SCT’s AbTHENEUM™ antibody discovery technology with Antibody Solutions’ broad antibody discovery service platform, enabling researchers to run a comprehensive discovery campaign with a single provider. SCT’s AbTHENEUM™ technology delivers paired VH and VL sequences with antigen binding and cross-reactivity data per cell, enabling intelligent candidate selection. “An increasing number of our clients want to explore ways to create antibodies beyond traditional technologies,” said Dr. John Kenney, co-founder and president of Antibody Solutions. “Joining forces with Single Cell Technology will allow us to offer clients access to an entirely new discovery channel that centers acutely on antibody-secreting B cells that may not be present in hybridoma or display platforms. The Antibody Solutions/SCT partnership can help identify a broader repertoire of antibody candidates and bring more effective therapeutics to market sooner." The ...
12/19/2013Antibody Solutions Announces Partnership with OMT, Inc.
Antibody Solutions announced today that it had entered into a strategic partnership with Open Monoclonal Technology to use human antibody transgenic OmniRat and OmniMouse to generate diverse portfolios of human therapeutic antibodies. This technology offers significant advantages over 1st generation transgenic animal platforms including a superior antibody response with greater antibody diversity. OmniRat shortens development time required to humanize antibodies obtained using non-transgenic animals. Antibody Solutions is a privately held antibody technology and services company based in Sunnyvale CA. Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for creation of human therapeutic antibodies, naturally optimized human antibodies, and the only company in the world with three transgenic animal platforms, OmniAb™.